05 Jun 2009
Multiple sclerosis (MS) patients may be negatively impacted by taking statins, a new study has suggested.
Researchers at McGill University, Canada, found that the treatment, which is widely used to lower blood cholesterol levels, may limit myelin repair in the body's central nervous system in patients treated with high daily doses.
Myelin, which forms a layer around the axon of a neuron, is essential in allowing the nervous system to function properly.
Study lead investigator Dr Veronique Miron explained that statins "are known to modify the immune system response and have a wide array of effects on other cellular processes".
Researchers added that, by understanding underlying mechanisms of statins, MS patients stand to benefit from "improved and enhanced treatment strategies", which would ultimately lead to an "improved quality of life".
MS is the most common progressive and disabling neurological condition among adults, with more than 2.5 million having developed the condition worldwide.
Click here to visit the Multiple Sclerosis Quick Guide
Delicious
Reddit
Facebook
StumbleUpon